CIK 0000886163 · Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770160744
- Phone
- 858-550-7500
- Business address
- 3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- 4 Grant or award Director acquired 1,142 shares (grant or award)
- 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 420 shares (to pay taxes)
- 8-K Event Shareholder vote results
- 4 Open-market sale Director sold 4,444 shares at $77.20 ($343,081)
- 144 Insider Sale of Securities
- 4 Open-market sale Director sold 6,408 shares at $77.13 ($494,225)
- 4 Open-market sale Director sold 6,408 shares at an average $76.56 ($490,628)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- CT ORDER Other Confidential Order
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale See Remarks sold 300 shares at $69.92 ($20,977)
- 8-K Event Other events
- 10-K Report Annual Report
- 4 Grant or award Chief Financial Officer acquired 6,046 shares (grant or award)
Page 17 of 115 · 2,300 filings